Sunday, May 19, 2019 10:24:27 PM
This excerpt is from a filing on August 22, 2017:
7) Controlling shareholder of the Company. Includes 10,000,000 shares of Series B Preferred Stock which are convertible into a total of 100,000,000 shares of common stock. Excludes 1,000 shares of Series A Preferred Stock held by Mr. Hovendick which have super-voting rights of 4 times the aggregate votes of all other classes of capital stock of the Company, and may vote with holders of the Company’s common stock on all matters which common stockholders may vote, but have no conversion, dividend, and liquidation rights. If the votes of the Series A and Series B Preferred Stock were taken into account, Mr. Hovendick would beneficially hold 87.74% of the voting securities of the Company.
Recent JPEX News
- Form 1-A POS - • Edgar (US Regulatory) • 09/25/2024 02:55:25 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 10/02/2023 04:15:09 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 09/28/2023 03:54:46 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM